# Concomitant Versus Hybrid Regimen for H. Pylori Eradication

> **NCT03592069** · PHASE4 · COMPLETED · sponsor: **Alexandra Hospital, Athens, Greece** · enrollment: 345 (actual)

## Conditions studied

- H.Pylori Infection
- H.Pylori Gastrointestinal Disease
- H. Pylori Associated Phlegmonous Gastritis

## Interventions

- **DRUG:** 10 day concomitant regimen
- **DRUG:** 14 day hybrid regimen

## Key facts

- **NCT ID:** NCT03592069
- **Lead sponsor:** Alexandra Hospital, Athens, Greece
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-21
- **Primary completion:** 2020-10-21
- **Final completion:** 2021-01-31
- **Target enrollment:** 345 (ACTUAL)
- **Last updated:** 2021-08-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03592069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03592069, "Concomitant Versus Hybrid Regimen for H. Pylori Eradication". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03592069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*